Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site.
Davies has over 15 years of experience the development, manufacture and commercialisation of recombinant protein therapeutics and joins F-star from CPI Biologics where he has served as head of analytical strategy, biologics since April 2014.
Prior to this, Davies worked at Swiss pharma supplier Lonza, which he joined as a scientist in 1997 and held several senior leadership roles in analytical strategy and development before being promoted to analytical services head in 2009.
John Haurum, chief executive officer of F-star, said: “We are pleased to welcome Mike to the team and look forward to working with him.
“His strong experience in the development and commercialisation of recombinant protein therapeutics will further enable us to progress our immune-oncology pipeline into the clinic.”